GlobeStar Therapeutics Corp Quarterly Debt-to-equity in % from Q2 2013 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
GlobeStar Therapeutics Corp quarterly Debt-to-equity history and growth rate from Q2 2013 to Q2 2024.
  • GlobeStar Therapeutics Corp Debt-to-equity for the quarter ending June 30, 2024 was -104 %, a 3.41% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 -104 -3.42 -3.41% Jun 30, 2024
Q1 2024 -103 -2.15 -2.14% Mar 31, 2024
Q4 2023 -100 +0.46 +0.46% Dec 31, 2023
Q3 2023 -100 +0.66 +0.65% Sep 30, 2023
Q2 2023 -100 +0.46 +0.46% Jun 30, 2023
Q1 2023 -100 +1.13 +1.11% Mar 31, 2023
Q4 2022 -100 +7.52 +6.96% Dec 31, 2022
Q3 2022 -101 +9.65 +8.73% Sep 30, 2022
Q2 2022 -101 +13.5 +11.8% Jun 30, 2022
Q1 2022 -102 +15.9 +13.6% Mar 31, 2022
Q4 2021 -108 +4.84 +4.29% Dec 31, 2021
Q3 2021 -111 +3.62 +3.17% Sep 30, 2021
Q2 2021 -114 +1.69 +1.46% Jun 30, 2021
Q1 2021 -118 +0.39 +0.33% Mar 31, 2021
Q4 2020 -113 +5.77 +4.87% Dec 31, 2020
Q3 2020 -114 +3.64 +3.09% Sep 30, 2020
Q2 2020 -116 +0.18 +0.16% Jun 30, 2020
Q1 2020 -118 -2.69 -2.34% Mar 31, 2020
Q4 2019 -119 -4.69 -4.12% Dec 31, 2019
Q3 2019 -118 -4.49 -3.96% Sep 30, 2019
Q2 2019 -116 -5.26 -4.74% Jun 30, 2019
Q1 2019 -115 -8.61 -8.08% Mar 31, 2019
Q4 2018 -114 -9.6 -9.2% Dec 31, 2018
Q3 2018 -113 -10.9 -10.6% Sep 30, 2018
Q2 2018 -111 -8.93 -8.75% Jun 30, 2018
Q1 2018 -107 +2.11K +95.2% Mar 31, 2018
Q4 2017 -104 -615 -120% Dec 31, 2017
Q3 2017 -102 -281 -157% Sep 30, 2017
Q2 2017 -102 -188 -218% Jun 30, 2017
Q1 2017 -2.22K -1.87K -529% Mar 31, 2017
Q4 2016 510 +940 Dec 31, 2016
Q3 2016 179 +605 Sep 30, 2016
Q2 2016 86.2 +476 Jun 30, 2016
Q1 2016 -353 +139 +28.3% Mar 31, 2016
Q4 2015 -430 +51.1 +10.6% Dec 31, 2015
Q3 2015 -427 +112 +20.7% Sep 30, 2015
Q2 2015 -390 +4.77K +92.5% Jun 30, 2015
Q1 2015 -492 -1.83K -137% Mar 31, 2015
Q4 2014 -481 -967 -199% Dec 31, 2014
Q3 2014 -538 -1.44K -160% Sep 30, 2014
Q2 2014 -5.16K -4.11K -389% Jun 30, 2014
Q1 2014 1.34K Mar 31, 2014
Q4 2013 486 Dec 31, 2013
Q3 2013 899 Sep 30, 2013
Q2 2013 -1.06K Jun 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.